Celltrion showcases Remsima SC at UEG Week

• Celltrion will attend UEG Week in Barcelona, Spain, Oct. 17-20, 2026, showcasing its inflammatory bowel disease portfolio led by Remsima SC.
• An Oct. 18 symposium will focus on subcutaneous infliximab across clinical scenarios.
• Two Meet the Experts sessions will address Remsima SC monotherapy and its potential role in complex Crohn's disease.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celltrion Inc. published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein.